The challenges of licensing drugs for use in pregnancy

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.14, Iss.13, 2013-09, pp. : 1707-1710

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antimalarial Drugs in Systemic Lupus Erythematosus: Use in Pregnancy

By Borden M.B. Parke A.L.

Drug Safety, Vol. 24, Iss. 14, 2001-01 ,pp. : 1055-1063

Adis International

Access to resources Recommend Favorite

Use of anti-asthmatic drugs during pregnancy. 3. Congenital malformations in the infants

By Källén Bengt Olausson Petra

European Journal of Clinical Pharmacology, Vol. 63, Iss. 4, 2007-04 ,pp. : 383-388

Springer Publishing Company

Access to resources Recommend Favorite

Use of Non-steroidal Anti-inflammatory Drugs in Pregnancy: Impact on the Fetus and Newborn

Current Drug Metabolism, Vol. 13, Iss. 4, 2012-05 ,pp. : 474-490

Bentham Science Publishers

Access to resources Recommend Favorite

Use of anti-asthmatic drugs during pregnancy. 1. Maternal characteristics, pregnancy and delivery complications

By Källén Bengt Otterblad Olausson Petra

European Journal of Clinical Pharmacology, Vol. 63, Iss. 4, 2007-04 ,pp. : 363-373

Springer Publishing Company

Access to resources Recommend Favorite

Out-licensing drugs to enhance access in developing countries

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 398, 2003-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite